| Pabal 100 micrograms/ml, solution for injection PA1009/021/001 |
Carbetocin |
Ferring Ireland Ltd |
Not marketed |
| Pabrinex Intravenous High Potency Concentrate for Solution for Infusion PA2242/017/001 |
Ascorbic acid, Riboflavin, Pyridoxine hydrochloride, Nicotinamide, Thiamine hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| Paclitaxel 6 mg/ml concentrate for solution for infusion PA2059/050/001 |
Paclitaxel |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Paclitaxel 6 mg/ml, Concentrate for Solution for Infusion PA2315/115/001 |
Paclitaxel |
Accord Healthcare Ireland Ltd. |
Marketed |
| Padcev 20 mg Powder for concentrate for solution for infusion EU/1/21/1615/001 |
Enfortumab Vedotin |
Astellas Pharma Europe B.V. |
— |
| Padcev 30 mg Powder for concentrate for solution for infusion EU/1/21/1615/002 |
Enfortumab Vedotin |
Astellas Pharma Europe B.V. |
— |
| Padolieve 500mg film coated tablets PA25373/001/001 |
Paracetamol |
A.forall Development |
Not marketed |
| Padolieve Max 1000mg film coated tablets PA25373/001/002 |
Paracetamol |
A.forall Development |
Not marketed |
| Paedisol Solution for Infusion PA2059/029/001 |
Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium acetate trihydrate |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Paglitaz EU/1/11/721/001-007 |
Pioglitazone hydrochloride |
KRKA, d.d., Novo mesto |
— |
| Paglitaz EU/1/11/721/008-014 |
Pioglitazone hydrochloride |
KRKA, d.d., Novo mesto |
— |
| Paglitaz EU/1/11/721/015-021 |
Pioglitazone hydrochloride |
KRKA, d.d., Novo mesto |
— |
| Palexia 100 mg film-coated tablets PA2242/012/003 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| PALEXIA 20 mg/ml oral solution PA2242/012/011 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| PALEXIA 4 mg/ml oral solution PA2242/012/010 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| Palexia 50 mg film-coated tablets PA2242/012/001 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| Palexia 75 mg film-coated tablets PA2242/012/002 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| Palexia SR 100 mg prolonged-release tablets PA2242/012/005 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| Palexia SR 150 mg prolonged-release tablets PA2242/012/006 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| Palexia SR 200 mg prolonged-release tablets PA2242/012/007 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| PALEXIA SR 25 mg prolonged-release tablets PA2242/012/009 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| Palexia SR 250 mg prolonged-release tablets PA2242/012/008 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| Palexia SR 50 mg prolonged-release tablets PA2242/012/004 |
Tapentadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| Palforzia 0.5 mg oral powder in capsules for opening Palforzia 1 mg oral powder in capsules for opening EU/1/20/1495/001 |
Arachis Hypogaea Allergens |
STALLERGENES |
— |
| Palforzia 1 mg oral powder in capsules for opening EU/1/20/1495/002-003 |
Arachis Hypogaea Allergens |
STALLERGENES |
— |
| Palforzia 10 mg oral powder in capsules for opening Palforzia 1 mg oral powder in capsules for opening EU/1/20/1495/004 |
Arachis Hypogaea Allergens |
STALLERGENES |
— |
| Palforzia 100 mg oral powder in capsules for opening EU/1/20/1495/011 |
Arachis Hypogaea Allergens |
STALLERGENES |
— |
| Palforzia 300 mg oral powder in sachet EU/1/20/1495/012-013 |
Arachis Hypogaea Allergens |
STALLERGENES |
— |
| Paliperidone Clonmel 100 mg prolonged-release suspension for injection in pre-filled syringe PA0126/370/003 |
Paliperidone palmitate |
Clonmel Healthcare Ltd |
Not marketed |
| Paliperidone Clonmel 150 mg prolonged-release suspension for injection in pre-filled syringe PA0126/370/004 |
Paliperidone palmitate |
Clonmel Healthcare Ltd |
Not marketed |
| Paliperidone Clonmel 50 mg prolonged-release suspension for injection in pre-filled syringe PA0126/370/001 |
Paliperidone palmitate |
Clonmel Healthcare Ltd |
Not marketed |
| Paliperidone Clonmel 75 mg prolonged-release suspension for injection in pre-filled syringe PA0126/370/002 |
Paliperidone palmitate |
Clonmel Healthcare Ltd |
Not marketed |
| Paliperidone Krka 3 mg prolonged-release tablets PA1347/092/001 |
Paliperidone |
KRKA, d.d., Novo mesto |
Marketed |
| Paliperidone Krka 6 mg prolonged-release tablets PA1347/092/002 |
Paliperidone |
KRKA, d.d., Novo mesto |
Marketed |
| Paliperidone Krka 9 mg prolonged-release tablets PA1347/092/003 |
Paliperidone |
KRKA, d.d., Novo mesto |
Marketed |
| Paliperidone Teva 100 mg prolonged-release suspension for injection PA0436/050/004 |
Paliperidone palmitate |
Norton Waterford |
Marketed |
| Paliperidone Teva 150 mg and Paliperidone Teva 100 mg prolonged-release suspension for injection PA0436/050/006 |
Paliperidone palmitate, Paliperidone palmitate |
Norton Waterford |
Not marketed |
| Paliperidone Teva 150 mg prolonged-release suspension for injection PA0436/050/005 |
Paliperidone palmitate |
Norton Waterford |
Marketed |
| Paliperidone Teva 25 mg prolonged-release suspension for injection PA0436/050/001 |
Paliperidone palmitate |
Norton Waterford |
Not marketed |
| Paliperidone Teva 50 mg prolonged-release suspension for injection PA0436/050/002 |
Paliperidone palmitate |
Norton Waterford |
Not marketed |
| Paliperidone Teva 75 mg prolonged-release suspension for injection PA0436/050/003 |
Paliperidone palmitate |
Norton Waterford |
Marketed |
| Palladone 1.3 mg hard capsules PA1688/007/001 |
Hydromorphone hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Palladone 2.6 mg hard capsules PA1688/007/002 |
Hydromorphone hydrochloride |
Mundipharma Pharmaceuticals Limited |
Not marketed |
| Palladone SR 2 mg prolonged release hard capsules PA1688/007/007 |
Hydromorphone hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Palladone SR 4 mg prolonged release hard capsules PA1688/007/008 |
Hydromorphone hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Palladone SR 8 mg prolonged release hard capsules, PA1688/007/009 |
Hydromorphone hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Palmeux 100 mg prolonged-release suspension for injection in pre-filled syringe PA1142/040/004 |
Paliperidone palmitate |
Amdipharm Limited |
— |
| Palmeux 150 mg prolonged-release suspension for injection in pre-filled syringe PA1142/040/005 |
Paliperidone palmitate |
Amdipharm Limited |
— |
| Palmeux 25 mg prolonged-release suspension for injection in pre-filled syringe PA1142/040/001 |
Paliperidone palmitate |
Amdipharm Limited |
— |
| Palmeux 50 mg prolonged-release suspension for injection in pre-filled syringe PA1142/040/002 |
Paliperidone palmitate |
Amdipharm Limited |
— |